C4 Therapeutics (CCCC) Current Leases (2019 - 2025)
Historic Current Leases for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $6.2 million.
- C4 Therapeutics' Current Leases rose 1036.93% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 1036.93%. This contributed to the annual value of $5.8 million for FY2024, which is 1063.42% up from last year.
- Latest data reveals that C4 Therapeutics reported Current Leases of $6.2 million as of Q3 2025, which was up 1036.93% from $6.1 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Current Leases high stood at $6.2 million for Q3 2025, and its period low was $1.1 million during Q1 2021.
- In the last 5 years, C4 Therapeutics' Current Leases had a median value of $5.0 million in 2023 and averaged $4.1 million.
- In the last 5 years, C4 Therapeutics' Current Leases surged by 28887.0% in 2022 and then surged by 1036.93% in 2025.
- C4 Therapeutics' Current Leases (Quarter) stood at $1.3 million in 2021, then soared by 252.32% to $4.7 million in 2022, then increased by 11.04% to $5.2 million in 2023, then increased by 10.63% to $5.8 million in 2024, then rose by 7.66% to $6.2 million in 2025.
- Its Current Leases was $6.2 million in Q3 2025, compared to $6.1 million in Q2 2025 and $5.9 million in Q1 2025.